Target intelligence / Profile preview

Biliverdin reductase B pseudogene

Molecular classification: Other (Pseudogene)

Overview

This genomic locus represents a processed pseudogene of the biliverdin reductase B (BLVRB) gene. Pseudogenes are DNA sequences generated by reverse transcription and retrotransposition of gene transcripts, usually lacking promoters and missing the ability to be transcribed into functional proteins[3]. As such, ENSG00000230840 does not encode a functional enzyme and has no direct role in biological processes, disease pathways, or therapeutic intervention. Pseudogenes can sometimes regulate gene expression post-transcriptionally (e.g., by acting as miRNA sponges), but there is no evidence for a specific regulatory function associated with this particular pseudogene[5][1].

Other names: Biliverdin reductase B (Flavin Reductase (NADPH)) pseudogeneBLVRB pseudogene

Beyond the preview

Go deeper on Biliverdin reductase B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biliverdin reductase B pseudogene.

Explore the full profile